학술논문

The proteolytic airway environment associated with pneumonia acts as a barrier for treatment with anti-infective antibodies
Document Type
Article
Source
In: European Journal of Pharmaceutics and Biopharmaceutics. (European Journal of Pharmaceutics and Biopharmaceutics, February 2024, 195)
Subject
Language
English
ISSN
18733441
09396411